Molecular pathogenesis of alpha-1-antitrypsin deficiency;Bases moléculaires du déficit en alpha-1 antitrypsine

Revue des Maladies Respiratoires

Volumn 31, Issue 10, 2014, Pages 992-1002

  Duvoix, A ^a   Roussel, B D ^a   Lomas, D A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Alpha 1 antitrypsin deficiency; Conformational disease; Liver disease; Misfolding; Protein evolution

Indexed keywords

ALPHA 1 ANTITRYPSIN; CARBAMAZEPINE; RAPAMYCIN; ALPHA 1-ANTITRYPSIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ALPHA 1 ANTITRYPSIN GENE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFORMATIONAL TRANSITION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EMPHYSEMA; GENE; HOMOZYGOTE; HUMAN; LIVER DISEASE; MOLECULAR PATHOLOGY; NONHUMAN; PLURIPOTENT STEM CELL; POLYMERIZATION; PROTEIN CONFORMATION; STEM CELL TRANSPLANTATION; ALPHA 1-ANTITRYPSIN DEFICIENCY; ANIMALS; CHEMISTRY; GENETICS; HUMANS; MODELS, MOLECULAR; PATHOLOGY; PROTEIN STRUCTURE, TERTIARY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; ANIMALS; HUMANS; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84922837806     PISSN: 07618425     EISSN: 17762588     Source Type: Journal    
DOI: 10.1016/j.rmr.2014.03.015     Document Type: Review

References (36)

1. Lomas DA, Evans DL, Finch JT, et al. The mechanism of Z 1-antitrypsin accumulation in the liver. Nature 1992;357:605-7.
2. Sveger T. Liver disease in alpha1-antitrypsin deficiencydetected by screening of 200,000 infants. N Engl J Med1976;294:1316-21.
3. Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primaryliver cancer in alpha1-antitrypsin deficiency. N Engl J Med1986;314:736-9.
4. Dafforn TR, Mahadeva R, Elliott PR, et al. A kinetic mech-anism for the polymerisation of 1-antitrypsin. J Biol Chem1999;274:9548-55.
5. James EL, Bottomley SP. The mechanism of 1-antitrypsin poly-merization probed by fluorescence spectroscopy. Arch BiochemBiophys 1998;356:296-300.
6. Gooptu B, Hazes B, Chang W-SW, et al. Inactive conformationof the serpin 1-antichymotrypsin indicates two stage insertionof the reactive loop; implications for inhibitory function andconformational disease. Proc Natl Acad Sci USA 2000;97:67-72.
7. Gooptu B, Lomas DA. Conformational pathology of the ser-pins-themes, variations and therapeutic strategies. Ann RevBiochem 2009;78:147-76.
8. Yamasaki M, Li W, Johnson DJ, et al. Crystal structure of a sta-ble dimer reveals the molecular basis of serpin polymerization.Nature 2008;455:1255-8.
9. Baek JH, Im H, Kang UB, et al. Probing the local conformationalchange of 1-antitrypsin. Protein Sci 2007;16:1842-50.
10. Takehara S, Zhang J, Yang X, et al. Refolding and polymeriza-tion pathways of neuroserpin. J Mol Biol 2010;403:751-62.
11. Ekeowa UI, Freekeb J, Miranda E, et al. Defining the mechanismof polymerization in the serpinopathies. Proc Natl Acad Sci USA2010;107:17146-51.
12. Belorgey D, Irving JA, Ekeowa UI, et al. Characterisation ofserpin polymers in vitro and in vivo. Methods 2011;53:255-66.
13. Lomas DA, Finch JT, Seyama K, et al. 1-antitrypsin Siiyama(Ser53Phe); further evidence for intracellular loop-sheet poly-merisation. J Biol Chem 1993;268:15333-5.
14. Lomas DA, Elliott PR, Sidhar SK, et al. Alpha1-antitrypsinMmalton (52Phe deleted) forms loop-sheet polymers in vivo:evidence for the C sheet mechanism of polymerisation. J BiolChem 1995;270:16864-70.
15. Miranda E, Pérez J, Ekeowa UI, et al. A novel monoclonalantibody to characterise pathogenic polymers in liver dis-ease associated with 1-antitrypsin deficiency. Hepatology2010;52:1078-88.
16. Stein PE, Carrell RW. What do dysfunctional serpins tellus about molecular mobility and disease? Nat Struct Biol1995;2:96-113.
17. Elliott PR, Bilton D, Lomas DA. Lung polymers in Z 1-antitrypsin related emphysema. Am J Respir Cell Mol Biol1998;18:670-4.
18. Mulgrew AT, Taggart CC, Lawless MW, et al. Z 1-antitrypsinpolymerizes in the lung and acts as a neutrophil chemoattrac-tant. Chest 2004;125:1952-7.
19. Mahadeva R, Atkinson C, Li J, et al. Polymers of Z 1-antitrypsinco-localise with neutrophils in emphysematous alveoli and arechemotactic in vivo. Am J Pathol 2005;166:377-86.
20. Gooptu B, Lomas DA. Polymers and inflammation: dis-ease mechanisms of the serpinopathies. J Exp Med2008;205:1529-34.
21. Alam S, Li Z, Janciauskiene S, et al. Oxidation of Z alpha-1-antitrypsin by cigarette smoke induces polymerization: a novelmechanism of early-onset emphysema. Am J Respir Cell MolBiol 2011;45:261-9.
22. Petrache I, Fijalkowska I, Medler TR, et al. Alpha-1 antit-rypsin inhibits caspase-3 activity, preventing lung endothelialcell apoptosis. Am J Pathol 2006;169:1155-66.
23. Petrache I, Fijalkowska I, Zhen L, et al. A novel antiapop-totic role for alpha1-antitrypsin in the prevention of pulmonaryemphysema. Am J Respir Crit Care Med 2006;173:1222-8.
24. Miranda E, Römisch K, Lomas DA. Mutants of neuroserpin thatcause dementia accumulate as polymers within the endoplas-mic reticulum. J Biol Chem 2004;279:28283-91.
25. Miranda E, McLeod I, Davies MJ, et al. The intracellular accu-mulation of polymeric neuroserpin explains the severity of thedementia FENIB. Hum Mol Genet 2008;17:1527-39.
26. Lomas DA, Mahadeva R. Alpha-1-antitrypsin polymerisation andthe serpinopathies: pathobiology and prospects for therapy. JClin Invest 2002;110:1585-90.
27. Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency.Lancet 2005;365:2225-36.
28. Burrows JAJ, Willis LK, Perlmutter DH. Chemical chaper-ones mediate increased secretion of mutant 1-antitrypsin( 1-AT) Z: a potential pharmacologcial strategy for preven-tion of liver injury and emphysema. Proc Natl Acad Sci USA2000;97:1796-801.
29. Teckman JH. Lack of effect of oral 4-phenylbutyrate on serumalpha-1-antitrypsin in patients with alpha-1-antitrypsin defi-ciency: a preliminary study. J Pediatr Gastroenterol Nutr2004;39:34-7.
30. Parfrey H, Mahadeva R, Ravenhill NA, et al. Targeting a surfacecavity of 1-antitrypsin to prevent conformational disease. JBiol Chem 2003;278:33060-6.
31. Mallya M, Phillips RL, Saldanha SA, et al. Small moleculesblock the polymerisation of Z 1-antitrypsin and increasethe clearance of intracellular aggregates. J Med Chem2007;50:5357-63.
32. Hidvegi T, Ewing M, Hale P, et al. An autophagy-enhancingdrug promotes degradation of mutant alpha1-antitrypsin Z andreduces hepatic fibrosis. Science 2010;329:229-32.
33. Kaushal S, Annamali M, Blomenkamp K, et al. Rapamycinreduces intrahepatic alpha-1-antitrypsin mutant Z proteinpolymers and liver injury in a mouse model. Exp Biol Med2010;235:700-9.
34. Marciniak SJ, Lomas DA. Alpha-1antitrypsin deficiency andautophagy. New Eng J Med 2010;363:1863-4.
35. Rashid ST, Corbineau S, Hannan N, et al. Modelinginherited metabolic disorders of the liver using humaninduced pluripotent stem cells. J Clin Invest 2010;120:3127-36.
36. Sarkar S, Floto RA, Berger Z, et al. Lithium inducesautophagy by inhibiting inositol monophosphatase. J Cell Biol2005;170:1101-11.